Boeing CEO Signals Slower-Than-Expected 737 Max Production Stabilization
Read source articleWhat happened
Boeing CEO Kelly Ortberg stated that stabilizing 737 Max production is taking longer than anticipated, with wing production at the Renton facility identified as a bottleneck. This comment comes amid the company's ongoing efforts to transition from 42 to 47 aircraft per month and eventually reach 52 per month, a key driver for cash flow recovery. The delay introduces near-term uncertainty around achieving sustained 47/month and may affect the timeline for certification of the new North Line and MAX 7/MAX 10 variants. Boeing's Q2 2026 results showed progress with 314 commercial deliveries and positive operating cash flow, but the production hold-up could slow inventory conversion and backlog monetization. The news aligns with the existing thesis that FAA-gated milestones remain the primary risk for the stock's valuation, which is currently at 30.2x EV/EBITDA.
Implication
Investors should monitor Renton wing production fixes and any updates on FAA production certification for the North Line, as these are critical for reaching the 47/month target and beyond. The delay could also postpone MAX 7/MAX 10 deliveries, affecting customers like Southwest and Ryanair, and potentially leading to order deferrals or reductions. With the stock trading at $232.79, above the attractive entry of $210, the risk-reward remains unattractive until clearer signs of production stabilization emerge. If the delay extends into Q4 2026, it may undermine the base case of $235 implied value and push the stock toward the bear case of $195. Conversely, any rapid resolution and progress on certifications could revive upside, but that is not yet evident.
Thesis delta
The core thesis remains intact but this news modestly reduces confidence in near-term execution. The WAIT rating is reinforced as the production delay directly impacts the timeline for the 47→52 rate increase and associated cash flow benefits. No immediate change to entry or trim levels is warranted, but the re-assessment window may need to extend if delays persist.
Confidence
High